Published in J Biol Chem on February 23, 2010
Structural insight into the type-II mitochondrial NADH dehydrogenases. Nature (2012) 1.03
Molecular characterization of a class I P450 electron transfer system from Novosphingobium aromaticivorans DSM12444. J Biol Chem (2010) 1.00
Structural biology of redox partner interactions in P450cam monooxygenase: a fresh look at an old system. Arch Biochem Biophys (2010) 0.92
Uncovering the role of hydrophobic residues in cytochrome P450-cytochrome P450 reductase interactions. Biochemistry (2011) 0.87
Molecular dynamics of the P450cam-Pdx complex reveals complex stability and novel interface contacts. Protein Sci (2014) 0.81
Another look at the interaction between mitochondrial cytochrome c and flavocytochrome b (2). Eur Biophys J (2011) 0.78
Structure and catalytic mechanism of monodehydroascorbate reductase, MDHAR, from Oryza sativa L. japonica. Sci Rep (2016) 0.75
Partial fusion of a cytochrome P450 system by carboxy-terminal attachment of putidaredoxin reductase to P450cam (CYP101A1). Catal Sci Technol (2016) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
High-resolution crystal structure of cytochrome P450cam. J Mol Biol (1987) 4.63
Cloning and sequencing of two tandem genes involved in degradation of 2,3-dihydroxybiphenyl to benzoic acid in the polychlorinated biphenyl-degrading soil bacterium Pseudomonas sp. strain KKS102. J Bacteriol (1989) 3.83
A soluble cytochrome P-450 functional in methylene hydroxylation. J Biol Chem (1968) 2.86
Photoreduction of the active site of the metalloprotein putidaredoxin by synchrotron radiation. Acta Crystallogr D Biol Crystallogr (2007) 1.37
Redox-dependent structural reorganization in putidaredoxin, a vertebrate-type [2Fe-2S] ferredoxin from Pseudomonas putida. J Mol Biol (2005) 1.19
Adrenodoxin: structure, stability, and electron transfer properties. Proteins (2000) 1.19
The structure of adrenodoxin reductase of mitochondrial P450 systems: electron transfer for steroid biosynthesis. J Mol Biol (1999) 1.17
Crystal structure of putidaredoxin reductase from Pseudomonas putida, the final structural component of the cytochrome P450cam monooxygenase. J Mol Biol (2004) 1.12
Adrenodoxin reductase-adrenodoxin complex structure suggests electron transfer path in steroid biosynthesis. J Biol Chem (2000) 1.12
Molecular mechanism of the redox-dependent interaction between NADH-dependent ferredoxin reductase and Rieske-type [2Fe-2S] ferredoxin. J Mol Biol (2007) 1.08
Crystal structure of putidaredoxin, the [2Fe-2S] component of the P450cam monooxygenase system from Pseudomonas putida. J Mol Biol (2003) 1.02
The putidaredoxin reductase-putidaredoxin electron transfer complex: theoretical and experimental studies. J Biol Chem (2005) 1.02
Putidaredoxin-to-cytochrome P450cam electron transfer: differences between the two reductive steps required for catalysis. Biochemistry (2006) 1.01
Laser flash induced electron transfer in P450cam monooxygenase: putidaredoxin reductase-putidaredoxin interaction. Biochemistry (2001) 0.90
Production and characterization of a functional putidaredoxin reductase-putidaredoxin covalent complex. Biochemistry (2010) 0.90
Probing the interactions of putidaredoxin with redox partners in camphor P450 5-monooxygenase by mutagenesis of surface residues. J Biol Chem (1997) 0.89
Equilibrium and kinetic studies of the interaction of cytochrome P-450cam and putidaredoxin. J Biol Chem (1982) 0.89
Isothermal titration calorimetric studies on the associations of putidaredoxin to NADH-putidaredoxin reductase and P450cam. Biochim Biophys Acta (1998) 0.85
Steady-state kinetic investigation of cytochrome P450cam: interaction with redox partners and reaction with molecular oxygen. Biochemistry (2004) 0.84
The reduction of putidaredoxin reductase by reduced pyridine nucleotides. Arch Biochem Biophys (1988) 0.84
NMR studies of putidaredoxin: associations of putidaredoxin with NADH-putidaredoxin reductase and cytochrome p450cam. Biochim Biophys Acta (1998) 0.82
Structure of C73G putidaredoxin from Pseudomonas putida. Acta Crystallogr D Biol Crystallogr (2004) 0.82
The oxidation of reduced putidaredoxin reductase by oxidized putidaredoxin. Arch Biochem Biophys (1988) 0.81
Putidaredoxin reductase, a new function for an old protein. J Biol Chem (2002) 0.81
Roles of negatively charged surface residues of putidaredoxin in interactions with redox partners in p450cam monooxygenase system. Biochim Biophys Acta (1998) 0.79
Engineered ascorbate peroxidase as a genetically encoded reporter for electron microscopy. Nat Biotechnol (2012) 2.98
Crystallographic study on the dioxygen complex of wild-type and mutant cytochrome P450cam. Implications for the dioxygen activation mechanism. J Biol Chem (2005) 1.77
Structure-function studies on nitric oxide synthases. J Inorg Biochem (2005) 1.69
The novel binding mode of N-alkyl-N'-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis. Biochemistry (2002) 1.65
Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy. Ann Neurol (2009) 1.58
Minimal pharmacophoric elements and fragment hopping, an approach directed at molecular diversity and isozyme selectivity. Design of selective neuronal nitric oxide synthase inhibitors. J Am Chem Soc (2008) 1.47
Unexpected binding modes of nitric oxide synthase inhibitors effective in the prevention of a cerebral palsy phenotype in an animal model. J Am Chem Soc (2010) 1.45
Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase. Nat Struct Mol Biol (2003) 1.45
High-resolution crystal structures and spectroscopy of native and compound I cytochrome c peroxidase. Biochemistry (2003) 1.44
Evolutionary history of a specialized p450 propane monooxygenase. J Mol Biol (2008) 1.40
Photoreduction of the active site of the metalloprotein putidaredoxin by synchrotron radiation. Acta Crystallogr D Biol Crystallogr (2007) 1.37
Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir. Proc Natl Acad Sci U S A (2010) 1.37
Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping. J Med Chem (2009) 1.37
Structural basis for novel delta-regioselective heme oxygenation in the opportunistic pathogen Pseudomonas aeruginosa. Biochemistry (2004) 1.36
Exploration of the active site of neuronal nitric oxide synthase by the design and synthesis of pyrrolidinomethyl 2-aminopyridine derivatives. J Med Chem (2010) 1.31
Structural studies of constitutive nitric oxide synthases with diatomic ligands bound. J Biol Inorg Chem (2006) 1.28
Crystal structures of the ferrous dioxygen complex of wild-type cytochrome P450eryF and its mutants, A245S and A245T: investigation of the proton transfer system in P450eryF. J Biol Chem (2005) 1.24
Crystallographic and single-crystal spectral analysis of the peroxidase ferryl intermediate. Biochemistry (2010) 1.23
Comparison of the heme-free and -bound crystal structures of human heme oxygenase-1. J Biol Chem (2002) 1.20
Holo- and apo-bound structures of bacterial periplasmic heme-binding proteins. J Biol Chem (2007) 1.18
Crystal structure and characterization of a cytochrome c peroxidase-cytochrome c site-specific cross-link. Proc Natl Acad Sci U S A (2004) 1.17
Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase. J Med Chem (2011) 1.15
Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors. J Med Chem (2003) 1.15
Structural basis for effector control and redox partner recognition in cytochrome P450. Science (2013) 1.15
Crystal structure of putidaredoxin reductase from Pseudomonas putida, the final structural component of the cytochrome P450cam monooxygenase. J Mol Biol (2004) 1.12
Potent, highly selective, and orally bioavailable gem-difluorinated monocationic inhibitors of neuronal nitric oxide synthase. J Am Chem Soc (2010) 1.10
Crystal structure of the cytochrome p450cam mutant that exhibits the same spectral perturbations induced by putidaredoxin binding. J Biol Chem (2004) 1.09
Redox-dependent structural changes in the Azotobacter vinelandii bacterioferritin: new insights into the ferroxidase and iron transport mechanism. Biochemistry (2006) 1.09
Crystal structures of the NO- and CO-bound heme oxygenase from Neisseriae meningitidis. Implications for O2 activation. J Biol Chem (2003) 1.09
Crystal structure of putidaredoxin, the [2Fe-2S] component of the P450cam monooxygenase system from Pseudomonas putida. J Mol Biol (2003) 1.02
Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK. J Biol Chem (2003) 1.02
The putidaredoxin reductase-putidaredoxin electron transfer complex: theoretical and experimental studies. J Biol Chem (2005) 1.02
Exploring the electron transfer properties of neuronal nitric-oxide synthase by reversal of the FMN redox potential. J Biol Chem (2008) 1.01
Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase. Bioorg Med Chem (2012) 1.01
Crystal structures of the ferric, ferrous, and ferrous-NO forms of the Asp140Ala mutant of human heme oxygenase-1: catalytic implications. J Mol Biol (2003) 1.01
Putidaredoxin-to-cytochrome P450cam electron transfer: differences between the two reductive steps required for catalysis. Biochemistry (2006) 1.01
A novel heme and peroxide-dependent tryptophan-tyrosine cross-link in a mutant of cytochrome c peroxidase. J Mol Biol (2003) 1.00
Structural and mechanistic insights into the interaction of cytochrome P4503A4 with bromoergocryptine, a type I ligand. J Biol Chem (2011) 1.00
Structure-guided design of selective inhibitors of neuronal nitric oxide synthase. J Med Chem (2013) 1.00
Geometric and electronic structures of the His-Fe(IV)=O and His-Fe(IV)-Tyr hemes of MauG. J Biol Inorg Chem (2012) 0.99
Double barrel shotgun scanning of the caveolin-1 scaffolding domain. ACS Chem Biol (2007) 0.99
DevS oxy complex stability identifies this heme protein as a gas sensor in Mycobacterium tuberculosis dormancy. Biochemistry (2009) 0.98
Interaction of human cytochrome P4503A4 with ritonavir analogs. Arch Biochem Biophys (2012) 0.98
Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems. Dalton Trans (2012) 0.97
Structures of the neuronal and endothelial nitric oxide synthase heme domain with D-nitroarginine-containing dipeptide inhibitors bound. Biochemistry (2004) 0.97
Peripheral but crucial: a hydrophobic pocket (Tyr(706), Leu(337), and Met(336)) for potent and selective inhibition of neuronal nitric oxide synthase. Bioorg Med Chem Lett (2010) 0.96
Crystal structure of human heme oxygenase-1 in a complex with biliverdin. Biochemistry (2004) 0.96
Crystallization of cytochromes P450 and substrate-enzyme interactions. Curr Top Med Chem (2004) 0.96
Exploring the binding conformations of bulkier dipeptide amide inhibitors in constitutive nitric oxide synthases. Biochemistry (2005) 0.96
Role of zinc in isoform-selective inhibitor binding to neuronal nitric oxide synthase . Biochemistry (2010) 0.96
Improved synthesis of chiral pyrrolidine inhibitors and their binding properties to neuronal nitric oxide synthase. J Med Chem (2011) 0.96
New understandings of thermostable and peizostable enzymes. Curr Opin Biotechnol (2003) 0.96
Structural and biological studies on bacterial nitric oxide synthase inhibitors. Proc Natl Acad Sci U S A (2013) 0.96
Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase. Bioorg Med Chem (2010) 0.94
Crystal structure of P450cin in a complex with its substrate, 1,8-cineole, a close structural homologue to D-camphor, the substrate for P450cam. Biochemistry (2004) 0.94
Dissecting cytochrome P450 3A4-ligand interactions using ritonavir analogues. Biochemistry (2013) 0.94
Mechanism of interaction between the general anesthetic halothane and a model ion channel protein, I: Structural investigations via X-ray reflectivity from Langmuir monolayers. Biophys J (2009) 0.94
Single crystal structural and absorption spectral characterizations of nitric oxide synthase complexed with N(omega)-hydroxy-L-arginine and diatomic ligands. Biochemistry (2009) 0.93
A model membrane protein for binding volatile anesthetics. Biophys J (2004) 0.93
Engineering ascorbate peroxidase activity into cytochrome c peroxidase. Biochemistry (2008) 0.93
Structural biology of redox partner interactions in P450cam monooxygenase: a fresh look at an old system. Arch Biochem Biophys (2010) 0.92
Preliminary characterization and crystal structure of a thermostable cytochrome P450 from Thermus thermophilus. J Biol Chem (2002) 0.92
High-resolution crystal structure of manganese peroxidase: substrate and inhibitor complexes. Biochemistry (2005) 0.92
Heme-coordinating inhibitors of neuronal nitric oxide synthase. Iron-thioether coordination is stabilized by hydrophobic contacts without increased inhibitor potency. J Am Chem Soc (2010) 0.91
Selective monocationic inhibitors of neuronal nitric oxide synthase. Binding mode insights from molecular dynamics simulations. J Am Chem Soc (2012) 0.91
Structure-based hypothesis on the activation of the CO-sensing transcription factor CooA. Acta Crystallogr D Biol Crystallogr (2007) 0.91
Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors. J Med Chem (2009) 0.91
Structure-based design and synthesis of N(omega)-nitro-L-arginine-containing peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Displacement of the heme structural water. J Med Chem (2007) 0.91
Crystal structure of the Leishmania major peroxidase-cytochrome c complex. Proc Natl Acad Sci U S A (2012) 0.90
Production and characterization of a functional putidaredoxin reductase-putidaredoxin covalent complex. Biochemistry (2010) 0.90
Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition. J Med Chem (2014) 0.89
Crystal structure of Leishmania major peroxidase and characterization of the compound i tryptophan radical. J Biol Chem (2011) 0.89
Mechanism of the CO-sensing heme protein CooA: new insights from the truncated heme domain and UVRR spectroscopy. J Inorg Biochem (2007) 0.88
Potent and selective double-headed thiophene-2-carboximidamide inhibitors of neuronal nitric oxide synthase for the treatment of melanoma. J Med Chem (2014) 0.88
Nitric oxide synthase inhibitors that interact with both heme propionate and tetrahydrobiopterin show high isoform selectivity. J Med Chem (2014) 0.88
Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines. J Biol Chem (2003) 0.87
The mobility of a conserved tyrosine residue controls isoform-dependent enzyme-inhibitor interactions in nitric oxide synthases. Biochemistry (2014) 0.87
Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions. Adv Exp Med Biol (2015) 0.87
Electrostatic control of the tryptophan radical in cytochrome c peroxidase. Biochemistry (2004) 0.87
Crystal structures of ferrous and ferrous-NO forms of verdoheme in a complex with human heme oxygenase-1: catalytic implications for heme cleavage. J Inorg Biochem (2004) 0.87
Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma. Antioxid Redox Signal (2013) 0.86
Pulsed electron paramagnetic resonance study of domain docking in neuronal nitric oxide synthase: the calmodulin and output state perspective. J Phys Chem A (2014) 0.85
Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir. J Med Chem (2013) 0.85
Spectroscopic and mutagenesis studies of human PGRMC1. Biochemistry (2015) 0.85
Ultrahigh (0.93A) resolution structure of manganese peroxidase from Phanerochaete chrysosporium: implications for the catalytic mechanism. J Inorg Biochem (2010) 0.85
Diatomic ligand discrimination by the heme oxygenases from Neisseria meningitidis and Pseudomonas aeruginosa. J Biol Chem (2006) 0.85
Communication between the zinc and tetrahydrobiopterin binding sites in nitric oxide synthase. Biochemistry (2014) 0.85
Crystal structure and properties of CYP231A2 from the thermoacidophilic archaeon Picrophilus torridus. Biochemistry (2008) 0.84
Electron transfer between cytochrome P450cin and its FMN-containing redox partner, cindoxin. J Biol Chem (2007) 0.84
The critical role of substrate-protein hydrogen bonding in the control of regioselective hydroxylation in p450cin. J Biol Chem (2008) 0.83
Leishmania major peroxidase is a cytochrome c peroxidase. Biochemistry (2012) 0.83
P450cin active site water: implications for substrate binding and solvent accessibility. Biochemistry (2013) 0.83
Role of electrostatics and salt bridges in stabilizing the compound I radical in ascorbate peroxidase. Biochemistry (2005) 0.83
Regiospecificity determinants of human heme oxygenase: differential NADPH- and ascorbate-dependent heme cleavage by the R183E mutant. J Biol Chem (2004) 0.83
Effect of DNA binding on geminate CO recombination kinetics in CO-sensing transcription factor CooA. J Biol Chem (2012) 0.83
Crystal structures and functional characterization of wild-type CYP101D1 and its active site mutants. Biochemistry (2013) 0.83
Structure-based design of bacterial nitric oxide synthase inhibitors. J Med Chem (2015) 0.82
Hydroxyl-terminated peptidomimetic inhibitors of neuronal nitric oxide synthase. Bioorg Med Chem (2006) 0.82
Synergistic effects of mutations in cytochrome P450cam designed to mimic CYP101D1. Biochemistry (2013) 0.82
Chiral linkers to improve selectivity of double-headed neuronal nitric oxide synthase inhibitors. Bioorg Med Chem Lett (2013) 0.82